Medulloblastoma with Extensive Nodularity: Single Photon Emission CT Study with Iodine-123 Metaiodobenzylguanidine

References

1. ↵
   Giangaspero F, Perilongo G, Fondelli MP, et al. Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg 1999;91:971–977

   PubMedWeb of Science
2. ↵
   Sugita Y, Miyagi J, Yamamoto T, et al. Neuroblastomas of the central nervous system: clinicopathological features of a cerebellar neuroblastoma in comparison with a metastatic cerebral neuroblastoma. Kurume Med J 1994;41:87–95

   PubMed
3. ↵
   Wafelman AR, Hoefnagel CA, Maes RAA, Beijnen JH. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med 1994;21:545–559

   PubMed
4. ↵
   Hoefnagel CA. Metaiodobenzyl guanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 1994;21:561–581

   PubMedWeb of Science
5. ↵
   Sasajima T, Kinouchi H, Tomura N, Watarai J, Mizoi K. High uptake of¹²³I -metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT. AJNR Am J Neuroradiol 2000;21:717–720

   Abstract/FREE Full Text
6. ↵
   Sasajima T, Kinouchi H, Tomura N, Watarai J, Mizoi K. Innovative approach in the diagnosis of medulloblastoma in which the ¹²³I -metaiodobenzylguanidine single-photon emission computerized tomography technique is used: case illustration. J Neurosurg 2000;93:145
7. ↵
   Iavarone A, Lasorella A, Servidei T, Riccardi R, Mastrangelo R. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines. Cancer Res 1993;53:304–309

   Abstract/FREE Full Text
8. ↵
   Giangaspero F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ. Medulloblastoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon, International Agency for Research on Cancer;2000;129–137
9. ↵
   Meyers SP, Kemp SS, Tarr RW. MR imaging features of medulloblastomas. AJR Am J Roentgenol 1992;158:859–865

   PubMedWeb of Science
10. ↵
    Kulkantrakorn K, Awwad EE, Levy B, et al. MRI in Lhermitte-Duclos disease. Neurology 1997;48:725–731

    Abstract/FREE Full Text
11. ↵
    Strickland DK, Vadyanathan G, Friedman HS, Zalutsky MR. Meta-[¹³¹I]iodobenzylguanidine uptake and meta-[²¹¹At]astatobenzylguanidine treatment in human medulloblastoma cell lines. J Neurooncol 1995;25:9–17

    PubMed
12. ↵
    Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D. Specific uptake of m-[¹²⁵I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res 1985;45:6366–6370

    Abstract/FREE Full Text
13. ↵
    Gaze MN, Huxham IM, Mairs RJ, Barrett A. Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging. Int J Cancer 1991;47:875–880

    PubMed
14. ↵
    Clerc J, Halpern S, Fourre C, et al. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice. J Nucl Med 1993;34:1565–1570

    Abstract/FREE Full Text
15. ↵
    Robson JA, Sidell N. Ultrastructural features of a human neuroblastoma cell line treated with retinoic acid. Neuroscience 1985;14:1149–1162

    CrossRefPubMed